Alpine Immune Sciences Inc reports results for the quarter ended in March - Earnings Summary

Alpine Immune Sciences

14/05/2021 02:07

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 45 cents​​ per share for the quarter ended
in March. The mean expectation of six analysts for the quarter
was for a loss of 36 cents per share.
* Revenue rose 193.7% to $3.20 million from a year ago; 
analysts expected $5.56 million. 
* Alpine Immune Sciences Inc's reported EPS for the quarter was
a loss of 45 cents​.
* The mean earnings estimate of analysts had fallen by
about 5,247.4% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Alpine Immune Sciences Inc shares had risen by 9.4% this
quarter and lost 7.9% so far this year.
* The company reported a quarterly loss of $10.64 million.
* Wall Street's median 12-month price target for Alpine Immune
Sciences Inc is $21.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 01:07 a.m. GMT.
​All figures in US dollars